That platform allows biotech companies to study real-world patient data to find treatments for such specialties as hematology, neurology and rare diseases. PicnicHealth said it plans to use the funding to assemble new datasets for 30 more medical conditions.
“Every day, across our healthcare system, we make decisions without the full benefit of data on what’s happening to patients out in the real world — what diseases really look like outside of narrow clinical trial populations, which symptoms matter most for patients’ quality of life, or which patients are actually benefiting from a particular treatment, to name a few,” Noga Leviner, CEO and co-founder of PicnicHealth, wrote in a blog post.
“And whether it’s a physician, a regulator, a drug developer or an insurance company making the decision — the impact on patients is real.”
The investment round was led by B Capital Group and brings PicnicHealth’s total funding to more than $100 million.
Adam Seabrook, partner at B Capital, said PicnicHealth — “with its easily accessible and detailed patient data — is well-positioned to be a leader” in healthcare’s digital transformation, according to a PicnicHealth news release.
Robert Mittendorff, MD, head of healthcare at B Capital, added that the company “breaks through the long-standing data silos in healthcare to put critical information in the hands of the people who need it most.”
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
